This application describes our proposal to establish the District of Columbia Center for AIDS Research (DC CFAR), building upon the strong scientific and administrative base that we have established over the past decade initially as the DC HIV/AIDS Institute from 2005-2009 and subsequently as a Developmental CFAR from 2010-2014. The DC CFAR represents a unique city-wide model which unites the complementary scientific efforts of the six major academic HIV/AIDS research institutions in Washington, DC - George Washington University, Georgetown University, Howard University, American University, the Children's National Medical Center and the Veterans Affairs Medical Center - and works in close collaboration with government and community partners. The HIV epidemic in Washington, DC is one of the most severe in the United States, with more than 16,000 persons living with HIV/AIDS, and an HIV prevalence rate of 2.5% among all adults and 5.7% among black men. Created to help address what had been a suboptimal response to the local epidemic, the DC D-CFAR has had a transformative impact on the HIV scientific landscape in DC -- helping to inform the public health response to the local epidemic, competing successfully for numerous NIH awards and administrative supplements, and recruiting and supporting a large cadre of both senior and early stage HIV investigators. However, despite recent progress in decreasing the number of newly reported HIV cases, nearly two new HIV cases are still diagnosed in DC each day. The Mission of the DC CFAR is to expand our multi-institutional effort to support research that contributes to ending the HIV epidemic in Washington, DC and beyond in partnership with government and community.
The Specific Aims of the DC CFAR are: 1) to provide scientific leadership and institutional infrastructure to advance HIV research in Washington, DC; 2) to stimulate and support innovative, interdisciplinary and translational HIV research; 3) to promote the development and recruitment of early stage, new, and women and minority HIV investigators; and 4) to advance HIV research in DC by increasing communication and collaboration among HIV investigators. The DC CFAR will support research in three primary scientific domains: HIV Prevention; Immunology, Virology and Pathogenesis; and Optimization of HIV Care and Treatment. These domains will be supported by five well-established Cores: Administrative Core A will provide overall scientific leadership and coordination; Developmental Core B will focus on providing support and mentorship to early stage, minority and new HIV investigators; and three Scientific Cores, Basic Sciences Core C, Clinical and Population Sciences Core D, and Social and Behavioral Sciences Core E, will provide services to support innovative, interdisciplinary and translational research. Lastly, the DC CFAR will support two Scientific Working Groups (SWGs) to promote research in two priority areas: the Highly Impacted Populations SWG and the Cure SWG.

Public Health Relevance

Washington, DC has one of the most severe urban HIV/AIDS epidemics in the United States, with 2.5% of adults living with HIV infection. The proposed District of Columbia Center for AIDS Research (DC CFAR) represents a city-wide consortium of 190 investigators at six academic research institutions who are deeply committed to conducting scientific research to help inform an effective public health response to the local and global epidemics. The DC CFAR will accomplish its mission by providing HIV scientists with pilot award funding, mentorship, and scientific services, and through the continued recruitment of both senior and junior HIV scientists.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
1P30AI117970-01
Application #
8897786
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Beaubien, Candice M
Project Start
2015-06-01
Project End
2020-05-31
Budget Start
2015-06-01
Budget End
2016-05-31
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
George Washington University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
043990498
City
Washington
State
DC
Country
United States
Zip Code
20052
Houzet, Laurent; PĂ©rez-Losada, Marcos; Matusali, Giulia et al. (2018) Seminal Simian Immunodeficiency Virus in Chronically Infected Cynomolgus Macaques Is Dominated by Virus Originating from Multiple Genital Organs. J Virol 92:
Macedo, Amanda B; Novis, Camille L; De Assis, Caroline M et al. (2018) Dual TLR2 and TLR7 agonists as HIV latency-reversing agents. JCI Insight 3:
Ren, Yanqin; Korom, Maria; Truong, Ronald et al. (2018) Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs. J Virol 92:
Orekhov, Alexander N; Pushkarsky, Tatiana; Oishi, Yumiko et al. (2018) HDL activates expression of genes stimulating cholesterol efflux in human monocyte-derived macrophages. Exp Mol Pathol 105:202-207
Huang, Szu-Han; Ren, Yanqin; Thomas, Allison S et al. (2018) Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. J Clin Invest 128:876-889
Adzhubei, Alexei A; Anashkina, Anastasia A; Tkachev, Yaroslav V et al. (2018) Modelling interaction between HIV-1 Nef and calnexin. AIDS 32:2103-2111
Clutton, Genevieve Tyndale; Jones, R Brad (2018) Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure. Front Immunol 9:1452
Ghosh, Mimi; Jais, Mariel; Biswas, Roshni et al. (2018) Immune biomarkers and anti-HIV activity in the reproductive tract of sexually active and sexually inactive adolescent girls. Am J Reprod Immunol 79:e12846
Wheeler, Darrell P; Lucas, Jonathan; Wilton, Leo et al. (2018) Building effective multilevel HIV prevention partnerships with Black men who have sex with men: experience from HPTN 073, a pre-exposure prophylaxis study in three US cities. J Int AIDS Soc 21 Suppl 7:e25180
Blankenship, Kim M; Del Rio Gonzalez, Ana Maria; Keene, Danya E et al. (2018) Mass incarceration, race inequality, and health: Expanding concepts and assessing impacts on well-being. Soc Sci Med 215:45-52

Showing the most recent 10 out of 98 publications